skip to content

Department of Pharmacology

Vascular Pharmacology


Key publications: 

1.          Hiley, C.R. (2009).  Endocannabinoids and the heart.  J. Cardiovasc. Pharmacol. 53: 267-276.
2.          Brown A.J. & Hiley, C.R. (2009) Chapter 5: Is GPR55 an anandamide receptor? Chapter 5: in "Anandamide, An Endogenous Cannabinoid. Vitamins and Hormones Vol. 81”" edited by G. Litwack. (Academic Press: New York). pp. 87-137.
3.          Garland C.J., Hiley C.R. & Dora K.A. (2011). EDHF: spreading the influence of the endothelium. Br. J. Pharmacol., 164:839-852.

Investigator biography

Robin Hiley read Medical Sciences and Natural Sciences in Cambridge. He subsequently carried out research on the muscarinic receptor and, in 1974, obtained a Ph.D. degree at the MRC Molecular Pharmacology Unit, Cambridge and the National Institute for Medical Research, London. He then took up a Lectureship in Pharmacology at the University of Liverpool before returning to Cambridge in 1980. He was made Reader in Vascular Pharmacology at the University of Cambridge in 2005. Robin was awarded the Cambridge Foundation (Pilkington) Prize for Teaching, is an editor of the British Journal of Pharmacology, and is Honorary Treasurer of the British Pharmacological Society. He has also been a visiting worker at the Faculté de Pharmacie, Université Louis Pasteur and Marion Merrell Dow in Strasbourg, at GlaxoSmithKline in King of Prussia (Pennsylvania), and at the Department of Pharmacology, University of Oxford. His current research interests include the effects of disease on blood vessel function, which can lead to hypertension, heart failure, coronary vascular disease and stroke. His research team's aims are to produce strategies for prevention and alleviation of organ damage arising from blood vessel malfunction by elucidating the physiological, cellular and molecular mechanisms of drug action on the vasculature and its endothelial lining.

Vascular Pharmacology
Dr Robin  Hiley

Contact Details

Not available for consultancy